Unlock instant, AI-driven research and patent intelligence for your innovation.

Bv8 nucleic acids and polypeptides with mitogenic activity

A cell proliferation and endothelial cell technology, applied in the direction of organic active ingredients, medical preparations containing active ingredients, animal cells, etc., can solve the problem of unclear properties of local beneficial signals

Inactive Publication Date: 2010-11-17
GENENTECH INC
View PDF69 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The local microenvironment profoundly affects the phenotype and growth properties of vascular endothelial cells in a tissue-specific or organ-specific manner, but the nature of the local beneficial signals themselves remains poorly understood

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bv8 nucleic acids and polypeptides with mitogenic activity
  • Bv8 nucleic acids and polypeptides with mitogenic activity
  • Bv8 nucleic acids and polypeptides with mitogenic activity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0442] Example 1 Northern blot analysis

[0443] To elucidate the expression pattern of Bv8, Northern blot analysis was performed with RNA from various tissues of human, mouse and rat. Human Northern blot with 32 P-labeled human Bv8 cDNA-based DNA probe hybridization, mouse and rat Northern blots with 32 P-labeled murine Bv8 cDNA-based DNA probe hybridization.

[0444] Northern blot analysis was performed according to methods known in the art. For example, with 30-50ng human or mouse cDNA fragments, Redi-Prime II Kit (Amersham), 32 P-dCTP 3000 μCi / mmol (Amersham) was used to prepare cDNA probes. Probes were purified on Sephadex G50 spin columns (Pharmacia) and hybridized in ExpressHyb hybridization solution (Stratagene) at 68°C. In another example, blots were incubated with probes in hybridization buffer (5X SSPE; 2X Denhardt's solution; 100 mg / mL denatured and sheared salmon sperm DNA; 50% formamide; 2% SDS) at 42°C for 60 Hours. Blots were washed several times in 2X...

Embodiment 2

[0446] Example 2 Analysis of Cell Proliferation

[0447] To determine the response of specific cell types to Bv8, the proliferative responses of bovine adrenal cortical capillary endothelial cells (ACE) and bovine brain capillary endothelial cells (BBC) were analyzed.

[0448] Briefly, ACE (adrenocortical capillary endothelial cells) and BBC (bovine brain capillary endothelial cells) were cultured in low glucose DMEM supplemented with 10% calf serum. For cell proliferation analysis, 6000 cells were plated in each well of a 12-well plate containing the above-mentioned medium, no control ("C" in Figure 11), 10 ng / ml VEGF ("V" in Figure 11 ”), 50, 10 or 1 nM Bv8 (Fc-tagged recombinant protein). Total cell counts were obtained after 1 week with a Coulter counter. Randomly set the control condition to 1 and obtain the fold increase in cell number relative to it. Media and other cell culture reagents were obtained from Life Technologies, Inc. The performance of the assay can b...

Embodiment 3

[0450] Example 3 Cell Survival Analysis

[0451] The effect of Bv8 on endothelial cell survival was examined. will be approximately 2x10 5Bovine brain capillary (BBC) cells were plated in each well of a 6-well plate containing complete medium (see Example 2). The next day, the complete medium was aspirated, and the cells were cultured in a medium without any additives, or in a medium containing one of the following components: 2% FCS, 10% FCS, 20ng / ml VEGF ( Figure 12 "V"), 5nM Bv8, 25nM Bv8, 20ng / ml VEGF+25nM Bv8 ( Figure 12 "V+Bv8"), or 25nM EG-VEGF. After 48 hours of incubation, cells were trypsinized, removed and fixed in cold 70% ethanol for several hours. Cells were then stained with 5 μg / ml propidium iodide and 20 ng / ml RNase in PBS for 2-4 hours at room temperature. Cells in sub-G1 phase were determined by FACS analysis. The percentage of the cell population as Figure 12 The percentage of apoptotic cells on the vertical axis is plotted.

[0452] Such as ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides methods of using Bv8 polypeptides to induce endothelial cell proliferation and to enhance endothelial cell survival. Also provided herein are methods of screening for modulators of Bv8 activity. Furthermore, methods of treatment using Bv8 polypeptides are provided.

Description

[0001] This application is a branch of the invention application with the application date of August 27, 2002, the application number 028209664 (the international application number is PCT / US02 / 27571), and the invention title is "Bv8 nucleic acid and polypeptide with mitogenic activity". case application. technical field [0002] The present invention generally relates to methods, compositions and assays utilizing protein Bv8 having mitogenic activity. Background technique [0003] Endothelial cells [0004] The local microenvironment profoundly affects the phenotype and growth properties of vascular endothelial cells in a tissue-specific or organ-specific manner, but the nature of the local beneficial signals themselves remains poorly understood. There are strong indications that both vascular endothelial growth factor (VEGF) and the angiopoietin family of endothelial cell-specific growth factors are required for embryonic development and angiogenesis in various physiolog...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/18A61K31/7088A61K48/00A61K39/395A61K45/00C12N5/071A61P1/00A61P3/10A61P5/24A61P5/38A61P13/00A61P15/00A61P15/08A61P35/00A61P43/00G01N33/50A61K38/00C07K14/475C12NC12N5/02C12N5/06C12N5/08C12N5/10C12N15/09C12Q1/02G01N33/15
CPCG01N33/5064G01N2500/00C07K14/475A61K38/00A61P1/00A61P13/00A61P15/00A61P15/08A61P35/00A61P43/00A61P5/00A61P5/24A61P5/38A61P3/10A61K48/00A61K39/00
Inventor 纳波利奥恩·弗拉拉詹妮弗·利考特
Owner GENENTECH INC